60%+ returns in 2025: Here’s how AI-powered stock investing has changed the game
Joseph H. Griffith IV, Chief Financial Officer of 908 Devices Inc. (NASDAQ:MASS), a company with a market capitalization of $274 million that has seen its stock surge over 240% year-to-date, sold 5,000 shares of common stock on September 19, 2025, for approximately $35,338.
The shares were sold at a weighted average price of $7.0677, with individual sales prices ranging from $7.03 to $7.14. The stock is currently trading near its 52-week high of $8.06, showing significant momentum with a 67% gain over the past six months. Following the transaction, Griffith directly owns 97,930 shares of 908 Devices Inc . InvestingPro analysis reveals 10+ additional insights about MASS’s valuation and momentum indicators.
The sale was executed under a Rule 10b5-1 trading plan. The company maintains a strong financial position, with a current ratio of 4.98 indicating robust liquidity, and holds more cash than debt on its balance sheet.
In other recent news, 908 Devices Inc. reported its financial results for the second quarter of 2025, showing a revenue increase to $13 million, which exceeded the analysts’ forecast of $12.17 million. This represents a 14% year-over-year growth in revenue. However, the company’s earnings per share (EPS) were below expectations, at -$0.37 compared to the anticipated -$0.17. In another development, Leerink Partners upgraded 908 Devices from Market Perform to Outperform, raising its price target from $5.00 to $12.00. This upgrade comes after 908 Devices’ shift to focus solely on forensics and threat detection following its divestiture from life sciences. Leerink Partners suggests this strategic change positions the company to potentially surpass its 20% growth expectations by 2026. These recent developments highlight significant changes and challenges for 908 Devices in the current market landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.